Literature DB >> 12359447

The positive transcription elongation factor activity of the vaccinia virus J3 protein is independent from its (nucleoside-2'-O-) methyltransferase and poly(A) polymerase stimulatory functions.

Donald R Latner1, Joseph M Thompson, Paul D Gershon, Carina Storrs, Richard C Condit.   

Abstract

Previous genetic and biochemical experiments have shown that the vaccinia virus J3 protein has three different roles in mRNA synthesis and modification. First, J3 is a (nucleoside-2'-O-)methyltransferase which methylates the 2' position of the first transcribed nucleotide, thus converting a cap-0 to a cap-1 structure at the 5' ends of mRNAs. Second, J3 is a processivity factor for the virus coded poly(A) polymerase. Third, J3 has recently been shown to have intermediate and late gene positive transcription elongation factor activity in vivo. Previous experiments have shown that the poly(A) polymerase stimulatory activity and the (nucleoside-2'-O-)methyltransferase activity are two independent functions of the protein that can be genetically separated through site-directed mutagenesis. In this article, the relationship between the J3-mediated transcription elongation activity and the two other functions of the protein was investigated by constructing several site-directed mutant viruses that contain specific defects in either methyltransferase or poly(A) polymerase processivity functions. The results demonstrate that the J3 positive transcription elongation factor activity is a third independent function of the protein that is genetically separable from its two other functions in mRNA modification. The results also show that neither the poly(A) polymerase stimulatory nor the methyltransferase activities of the J3 protein is essential for virus growth in cell culture.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12359447     DOI: 10.1006/viro.2002.1538

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

1.  Autographa californica nucleopolyhedrovirus orf69 encodes an RNA cap (nucleoside-2'-O)-methyltransferase.

Authors:  Xiaofeng Wu; Linda A Guarino
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  Marker rescue mapping of the combined Condit/Dales collection of temperature-sensitive vaccinia virus mutants.

Authors:  Sayuri E M Kato; Nissin Moussatche; Susan M D'Costa; Travis W Bainbridge; Cindy Prins; Audra L Strahl; Amber N Shatzer; Alyson J Brinker; Nicole E Kay; Richard C Condit
Journal:  Virology       Date:  2008-03-07       Impact factor: 3.616

3.  Roles of LEF-4 and PTP/BVP RNA triphosphatases in processing of baculovirus late mRNAs.

Authors:  Yi Li; Linda A Guarino
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

4.  A targeted approach to identification of vaccinia virus postreplicative transcription elongation factors: genetic evidence for a role of the H5R gene in vaccinia transcription.

Authors:  Steven G Cresawn; Richard C Condit
Journal:  Virology       Date:  2007-03-21       Impact factor: 3.616

5.  Identification of Vaccinia Virus Replisome and Transcriptome Proteins by Isolation of Proteins on Nascent DNA Coupled with Mass Spectrometry.

Authors:  Tatiana G Senkevich; George C Katsafanas; Andrea Weisberg; Lisa R Olano; Bernard Moss
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

6.  Mapping and phenotypic analysis of spontaneous isatin-beta-thiosemicarbazone resistant mutants of vaccinia virus.

Authors:  Steven G Cresawn; Cindy Prins; Donald R Latner; Richard C Condit
Journal:  Virology       Date:  2007-03-01       Impact factor: 3.616

7.  An Amsacta moorei entomopoxvirus ortholog of the poly(A) polymerase small subunit exhibits methyltransferase activity and is non-essential for virus growth.

Authors:  Marie N Becker; Tracie M Todd; Richard W Moyer
Journal:  Virology       Date:  2008-03-26       Impact factor: 3.616

Review 8.  Orthopoxvirus targets for the development of new antiviral agents.

Authors:  Mark N Prichard; Earl R Kern
Journal:  Antiviral Res       Date:  2012-03-08       Impact factor: 10.103

9.  2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members.

Authors:  Stephane Daffis; Kristy J Szretter; Jill Schriewer; Jianqing Li; Soonjeon Youn; John Errett; Tsai-Yu Lin; Stewart Schneller; Roland Zust; Hongping Dong; Volker Thiel; Ganes C Sen; Volker Fensterl; William B Klimstra; Theodore C Pierson; R Mark Buller; Michael Gale; Pei-Yong Shi; Michael S Diamond
Journal:  Nature       Date:  2010-11-18       Impact factor: 49.962

10.  Evolution-guided functional analyses reveal diverse antiviral specificities encoded by IFIT1 genes in mammals.

Authors:  Matthew D Daugherty; Aaron M Schaller; Adam P Geballe; Harmit S Malik
Journal:  Elife       Date:  2016-05-31       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.